en
Scientific article
English

Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpraparat bei Intoleranz gegenuber nichtsteroidalen Antiphlogistika

Other titleThe selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs
Published inMedizinische Klinik, vol. 98, no. 5, p. 242-244
Publication date2003
Abstract

BACKGROUND: Adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are frequent, and the need to identify a safe alternative drug is a common problem in clinical practice. We assessed the tolerability of the selective cyclooxygenase-2 inhibitor celecoxib in a group of NSAID-sensitive patients. PATIENTS AND METHODS: 77 patients (24 males, 53 females, age 31-80 years) with a history of adverse reactions to NSAIDs underwent standardized skin prick, scratch and patch tests along with oral, placebo-controlled blinded exposure to celecoxib (maximum single dose 200 mg, cumulative daily dose 350 mg). RESULTS: 21 patients had a history of cutaneous reactions only (urticaria), 25 had encountered respiratory symptoms (asthma), 18 reported cutaneous as well as respiratory symptoms, and in 13 patients an anaphylactoid shock occurred. Acetylsalicylic acid triggered symptoms in 38 patients. In 46 cases, several NSAIDs of different chemical groups caused symptoms. Oral challenge with celecoxib was tolerated by all 77 patients without adverse effects. CONCLUSION: This study demonstrates that celecoxib does not have cross-intolerance to NSAIDs. Celecoxib is a safe alternative in subjects with previous adverse reactions to NSAIDs.

Keywords
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal/*adverse effects/therapeutic use
  • Cyclooxygenase Inhibitors/adverse effects/*therapeutic use
  • Drug Hypersensitivity/*etiology/prevention & control
  • Female
  • Humans
  • Intradermal Tests
  • Male
  • Middle Aged
  • Pyrazoles
  • Single-Blind Method
  • Sulfonamides/adverse effects/*therapeutic use
Affiliation Not a UNIGE publication
Citation (ISO format)
AHLBACH, Sandra et al. Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpraparat bei Intoleranz gegenuber nichtsteroidalen Antiphlogistika. In: Medizinische Klinik, 2003, vol. 98, n° 5, p. 242–244. doi: 10.1007/s00063-003-1251-3
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0723-5003
470views
0downloads

Technical informations

Creation09/20/2013 4:48:43 PM
First validation09/20/2013 4:48:43 PM
Update time03/14/2023 8:25:48 PM
Status update03/14/2023 8:25:47 PM
Last indexation02/12/2024 8:33:08 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack